Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy, achieving the primary goal in a late-stage ...
The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small ...
StudyFinds' Dr. Faith Coleman speaks with the doctor testing a new vitamin C treatment that may double the survival time of ...
Mark Spain, who was an evening anchor at Action News Jax from 2007 to 2014, revealed in a post on his professional Facebook ...
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
Theriva Biologics, Inc. recently disclosed the outcomes of a Type D meeting with the U.S. Food and Drug Administration (FDA), outlining details regarding the design of a Phase 3 clinical study ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.